Search

Search Constraints

You searched for: Author/Creator Vesterhus, Mette

Search Results

1. Anti-GP2 IgA autoantibodies are associated with poor survival and cholangiocarcinoma in primary sclerosing cholangitis. Issue 1 (12th July 2016)

2. Antineutrophil antibodies define clinical and genetic subgroups in primary sclerosing cholangitis. (13th September 2016)

3. Associations of neopterin and kynurenine–tryptophan ratio with survival in primary sclerosing cholangitis. (3rd April 2021)

4. Cholangiocarcinoma is associated with a raised enhanced liver fibrosis score independent of primary sclerosing cholangitis. (18th March 2019)

5. Circulating Macrophage Activation Markers Predict Transplant-Free Survival in Patients With Primary Sclerosing Cholangitis. Issue 3 (1st March 2021)

6. Circulating markers of gut barrier function associated with disease severity in primary sclerosing cholangitis. (24th October 2018)

7. Elevated interleukin‐8 in bile of patients with primary sclerosing cholangitis. (16th March 2016)

8. Elevated trimethylamine-N-oxide (TMAO) is associated with poor prognosis in primary sclerosing cholangitis patients with normal liver function. Issue 4 (June 2017)

9. Elevated trimethylamine‐N ‐oxide (TMAO) is associated with poor prognosis in primary sclerosing cholangitis patients with normal liver function. Issue 4 (1st June 2017)

10. Enhanced liver fibrosis score predicts transplant‐free survival in primary sclerosing cholangitis. Issue 1 (28th April 2015)